ASTROTECH Corp Revenue from Contract with Customer, Including Assessed Tax
ASTROTECH Corp (ASTC) reported Revenue from Contract with Customer, Including Assessed Tax of $343.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-08-06
- ASTROTECH Corp revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $343.00K, a 35.77% decline year-over-year.
- ASTROTECH Corp revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $148.00K, a 43.30% decline year-over-year.
- ASTROTECH Corp revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $297.00K, a 773.53% increase year-over-year.
- ASTROTECH Corp revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $220.00K, a 197.30% increase year-over-year.
- ASTROTECH Corp revenue from contract with customer, including assessed tax for fiscal 2025 was $1.05M, a 36.96% decline from fiscal 2024.
- ASTROTECH Corp revenue from contract with customer, including assessed tax for fiscal 2024 was $1.66M, a 121.87% increase from fiscal 2023.
- ASTROTECH Corp revenue from contract with customer, including assessed tax for fiscal 2023 was $750.00K, a 13.69% decline from fiscal 2022.
- ASTROTECH Corp revenue from contract with customer, including assessed tax for fiscal 2022 was $869.00K, a 160.18% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | $343.00K 10-Q/A · filed 2026-08-06 | $491.00K derived: sum of 2 quarters · filed 2026-08-06 | $787.00K 10-Q/A · filed 2026-08-06 | $1.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $148.00K 10-Q · filed 2026-02-13 | $445.00K 10-Q · filed 2026-02-13 | $665.00K derived: sum of 3 quarters · filed 2026-02-13 | $1.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $297.00K 10-Q · filed 2025-11-13 | $517.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.05M derived: sum of 3 quarters · filed 2026-08-06 | $1.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $220.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-26 | $754.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.01M derived: sum of 3 quarters · filed 2026-08-06 | $1.05M 10-K · filed 2025-09-26 |
| 2025-03-31 | $534.00K 10-Q/A · filed 2026-08-06 | $795.00K derived: sum of 2 quarters · filed 2026-08-06 | $829.00K 10-Q/A · filed 2026-08-06 | $903.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $261.00K 10-Q · filed 2026-02-13 | $295.00K 10-Q · filed 2026-02-13 | $369.00K derived: sum of 3 quarters · filed 2026-02-13 | $419.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $34.00K 10-Q · filed 2025-11-13 | $108.00K derived: sum of 2 quarters · filed 2025-11-13 | $158.00K derived: sum of 3 quarters · filed 2025-11-13 | $1.27M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $124.00K derived: sum of 2 quarters · filed 2025-09-26 | $1.24M derived: sum of 3 quarters · filed 2025-09-26 | $1.66M 10-K · filed 2025-09-26 |
| 2024-03-31 | $50.00K 10-Q · filed 2025-05-14 | $1.17M derived: sum of 2 quarters · filed 2025-05-14 | $1.59M 10-Q · filed 2025-05-14 | $2.00M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.11M 10-Q · filed 2025-02-14 | $1.54M 10-Q · filed 2025-02-14 | $1.95M derived: sum of 3 quarters · filed 2025-02-14 | $1.99M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $425.00K 10-Q · filed 2024-11-13 | $839.00K derived: sum of 2 quarters · filed 2024-11-13 | $874.00K derived: sum of 3 quarters · filed 2024-11-13 | $1.14M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | $449.00K derived: sum of 2 quarters · filed 2024-09-20 | $712.00K derived: sum of 3 quarters · filed 2024-09-20 | $750.00K 10-K · filed 2024-09-20 |
| 2023-03-31 | $35.00K 10-Q · filed 2024-05-14 | $298.00K derived: sum of 2 quarters · filed 2024-05-14 | $336.00K 10-Q · filed 2024-05-14 | $360.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $263.00K 10-Q · filed 2024-02-13 | $301.00K 10-Q · filed 2024-02-13 | $325.00K derived: sum of 3 quarters · filed 2024-02-13 | $422.00K derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $38.00K 10-Q · filed 2023-11-13 | $62.00K derived: sum of 2 quarters · filed 2023-11-13 | $159.00K derived: sum of 3 quarters · filed 2023-11-13 | $720.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $121.00K derived: sum of 2 quarters · filed 2023-09-28 | $682.00K derived: sum of 3 quarters · filed 2023-09-28 | $869.00K 10-K · filed 2023-09-28 |
| 2022-03-31 | $97.00K 10-Q · filed 2023-05-12 | $658.00K derived: sum of 2 quarters · filed 2023-05-12 | $845.00K 10-Q · filed 2023-05-12 | $855.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $561.00K 10-Q · filed 2023-02-13 | $748.00K 10-Q · filed 2023-02-13 | $758.00K derived: sum of 3 quarters · filed 2023-02-13 | $812.00K derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-09-30 | $187.00K 10-Q · filed 2022-11-14 | $197.00K derived: sum of 2 quarters · filed 2022-11-14 | $251.00K derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15 | $64.00K derived: sum of 2 quarters · filed 2022-09-15 | $334.00K 10-K · filed 2022-09-15 | |
| 2021-03-31 | $54.00K 10-Q · filed 2022-05-13 | $324.00K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |